Your browser doesn't support javascript.
loading
Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial.
Siedner, Mark J; Moosa, Mahomed-Yunus S; McCluskey, Suzanne; Gilbert, Rebecca F; Pillay, Selvan; Aturinda, Isaac; Ard, Kevin; Muyindike, Winnie; Musinguzi, Nicholas; Masette, Godfrey; Pillay, Melendhran; Moodley, Pravikrishnen; Brijkumar, Jaysingh; Rautenberg, Tamlyn; George, Gavin; Gandhi, Rajesh T; Johnson, Brent A; Sunpath, Henry; Bwana, Mwebesa B; Marconi, Vincent C.
Afiliação
  • Siedner MJ; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, Mbarara University of Science and Technology, Mbarara, Uganda, Africa Health Research Institute, KwaZulu-Natal, South Africa, and University of KwaZulu-Natal, Durban, South Africa (M.J.S.).
  • Moosa MS; University of KwaZulu-Natal, Durban, South Africa (M.S.M., S.P., J.B., G.G., H.S.).
  • McCluskey S; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (S.M., K.A., R.T.G.).
  • Gilbert RF; Massachusetts General Hospital, Boston, Massachusetts (R.F.G.).
  • Pillay S; University of KwaZulu-Natal, Durban, South Africa (M.S.M., S.P., J.B., G.G., H.S.).
  • Aturinda I; Mbarara University of Science and Technology, Mbarara, Uganda (I.A., W.M., N.M., G.M., M.B.B.).
  • Ard K; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (S.M., K.A., R.T.G.).
  • Muyindike W; Mbarara University of Science and Technology, Mbarara, Uganda (I.A., W.M., N.M., G.M., M.B.B.).
  • Musinguzi N; Mbarara University of Science and Technology, Mbarara, Uganda (I.A., W.M., N.M., G.M., M.B.B.).
  • Masette G; Mbarara University of Science and Technology, Mbarara, Uganda (I.A., W.M., N.M., G.M., M.B.B.).
  • Pillay M; National Health Laboratory Service, Durban, South Africa (M.P., P.M.).
  • Moodley P; National Health Laboratory Service, Durban, South Africa (M.P., P.M.).
  • Brijkumar J; University of KwaZulu-Natal, Durban, South Africa (M.S.M., S.P., J.B., G.G., H.S.).
  • Rautenberg T; Griffith University, Brisbane, Queensland, Australia (T.R.).
  • George G; University of KwaZulu-Natal, Durban, South Africa (M.S.M., S.P., J.B., G.G., H.S.).
  • Gandhi RT; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (S.M., K.A., R.T.G.).
  • Johnson BA; University of Rochester, Rochester, New York (B.A.J.).
  • Sunpath H; University of KwaZulu-Natal, Durban, South Africa (M.S.M., S.P., J.B., G.G., H.S.).
  • Bwana MB; Mbarara University of Science and Technology, Mbarara, Uganda (I.A., W.M., N.M., G.M., M.B.B.).
  • Marconi VC; Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia (V.C.M.).
Ann Intern Med ; 174(12): 1683-1692, 2021 12.
Article em En | MEDLINE | ID: mdl-34698502
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Terapia Antirretroviral de Alta Atividade / Farmacorresistência Viral Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Terapia Antirretroviral de Alta Atividade / Farmacorresistência Viral Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article